Vincent Lambert

University of Liège

Papers

1

Total Citations

121

H-Index

1

About

Vincent Lambert is a leading investigator in ocular angiogenesis and retinal disease, best known for his pioneering work on the role of matrix metalloproteinases (MMPs) in pathological neovascularization. His landmark 2002 study, "Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization," which has garnered over 120 citations, established MMP-9 as a critical mediator in the development of choroidal neovascularization—a hallmark of age-related macular degeneration. This work provided the first direct evidence that targeting MMP-9 could offer a therapeutic strategy for preventing vision loss. Lambert's research has profoundly shaped our understanding of the extracellular matrix remodeling that drives abnormal blood vessel growth in the eye, bridging basic molecular biology with clinical ophthalmology. His contributions have been instrumental in advancing anti-angiogenic therapies and have inspired subsequent investigations into MMP inhibitors as potential treatments for retinal disorders. For students and researchers, Lambert’s work exemplifies how a focused mechanistic study can illuminate a disease pathway and open new avenues for intervention, making him a respected figure in the field of ocular vascular biology.

Research Focus

Key Achievements

1
H-Index
1
Papers
121
Total Citations
121
Avg Citations/Paper
🏆 Most Cited Paper
Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization
121 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of Liège

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago